Clinical Trial Update: Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing applications and performance of the Bravo pH Monitoring System for gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Bravo pH Monitoring System

Snippet

Sponsor: Medtronic - MITG | Conditions: Gastro Esophageal Reflux Disease | Phase 4 | Status: COMPLETED